Skip to content
Ep. 153 - The Inflation Reduction Act episode artwork

Dec 19, 2022 19 min

Ep. 153 - The Inflation Reduction Act

from BioCentury This Week Hosted by BioCentury

A strategy for navigating the Inflation Reduction Act is essential for every biopharma company, regardless of size or location, Washington Editor Steve Usdin said on a special edition of the BioCentury This Week podcast. Usdin and his BioCentury colleagues discuss why creating an IRA strategy is so complex, when and how CMS is going to set prices for drugs selected for scrutiny and what the chances are that the act can be repealed or modified. Reach us by sending a text

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Ep. 153 - The Inflation Reduction Act

0:00 19:24

Chapters

  1. 0:17 IRA's Broad Impact
  2. 8:46 Effect on Cancer Drug Development
  3. 10:47 Big vs Small Companies
  4. 14:50 What's Next

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of BioCentury This Week?

This episode is 19 minutes long.

When was this BioCentury This Week episode published?

This episode was published on December 19, 2022.

Can I download this BioCentury This Week episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.